Key Takeaways
- • TPG is exploring a sale of Lyric, its healthcare software company, in a process that could value the business at approximately $5 billion, according to sources familiar with the matter.
- • JPMorgan Chase has been engaged as the investment banker advising on the potential transaction, though sources cautioned that no sale is guaranteed at this stage.
- • Lyric generates approximately $250 million in annual EBITDA, providing a foundation for the $5 billion valuation and indicating strong underlying operational performance in healthcare payments software.
- • The sale process signals TPG's potential intent to monetize the healthcare software asset, which supports payment infrastructure across the healthcare industry.
Summary
TPG is actively exploring the sale of Lyric, a healthcare software company focused on payment processing infrastructure, in a process that could value the business at around $5 billion, according to exclusive reporting from Reuters. The private equity firm has retained JPMorgan Chase to advise on the potential transaction as it evaluates strategic options for the asset.
Lyric's financial performance underscores the scale of the potential deal. The company generates approximately $250 million in annual EBITDA, a metric that typically anchors enterprise valuation multiples in the software sector. This level of cash generation suggests Lyric has achieved meaningful market penetration in healthcare payments, a sector characterized by structural demand and recurring revenue dynamics that appeal to both financial and strategic buyers.
The engagement of JPMorgan Chase as lead advisor indicates that TPG is pursuing a formal sales process, though sources emphasized that no transaction is assured. The presence of an investment banker typically signals serious intent, often suggesting that management has approved an exploratory phase that could lead to a formal auction or direct negotiations with prospective acquirers. Given the $5 billion valuation implied in the process, potential buyers could include larger healthcare technology platforms, alternative investment firms with healthcare exposure, or strategic consolidators in the payments or healthcare IT sectors.
The timing of this process reflects broader trends in private equity, where operators are actively managing portfolio exit windows and assessing market conditions for healthcare software assets. The healthcare payments sector has attracted sustained institutional interest due to secular growth drivers, regulatory tailwinds supporting digital infrastructure, and mission-critical operational positioning within hospital systems and provider networks.
Lyric's financial performance underscores the scale of the potential deal. The company generates approximately $250 million in annual EBITDA, a metric that typically anchors enterprise valuation multiples in the software sector. This level of cash generation suggests Lyric has achieved meaningful market penetration in healthcare payments, a sector characterized by structural demand and recurring revenue dynamics that appeal to both financial and strategic buyers.
The engagement of JPMorgan Chase as lead advisor indicates that TPG is pursuing a formal sales process, though sources emphasized that no transaction is assured. The presence of an investment banker typically signals serious intent, often suggesting that management has approved an exploratory phase that could lead to a formal auction or direct negotiations with prospective acquirers. Given the $5 billion valuation implied in the process, potential buyers could include larger healthcare technology platforms, alternative investment firms with healthcare exposure, or strategic consolidators in the payments or healthcare IT sectors.
The timing of this process reflects broader trends in private equity, where operators are actively managing portfolio exit windows and assessing market conditions for healthcare software assets. The healthcare payments sector has attracted sustained institutional interest due to secular growth drivers, regulatory tailwinds supporting digital infrastructure, and mission-critical operational positioning within hospital systems and provider networks.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.